Vericel (VCEL) Interest Expenses (2010 - 2026)
Vericel (VCEL) reported Interest Expenses of $625000.0 for Q1 2026, little changed on a YoY basis from $625000.0 in Q1 2025, and up 285.8% sequentially from $162000.0 in Q4 2025.
Vericel (VCEL) Interest Expenses (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 17 years of Interest Expenses data on file, last reported at $625000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses changed 0.0% year-over-year to $625000.0; the trailing twelve-month figure through Mar 2026 stood at $625000.0 (changed 0.0% YoY), and the FY2025 full-year result was $41.2 million, down 70.01% from the prior year.
- Interest Expenses advanced to $625000.0 in Q1 2026, from $162000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $157.8 million in Q3 2023 to a low of $18000.0 in Q1 2022.
- A 5-year average of $12.7 million and a median of $625000.0 in 2023 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses soared 254980.0% in 2023 and sank 99.6% in 2024, its largest moves.
- Tracing VCEL's Interest Expenses over 5 years: stood at $957000.0 in 2022, then decreased by 21.0% to $756000.0 in 2023, then sank by 79.63% to $154000.0 in 2024, then climbed by 5.19% to $162000.0 in 2025, then soared by 285.8% to $625000.0 in 2026.
- Business Quant data shows VCEL's Interest Expenses at $625000.0 in Q1 2026, $162000.0 in Q4 2025, and $625000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 625,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 625,000.00 |
| Mar 31, 2026 | 625,000.00 |
| Dec 31, 2025 | 162,000.00 |
| Dec 31, 2025 | 162,000.00 |
| Sep 30, 2025 | 625,000.00 |
| Sep 30, 2025 | 625,000.00 |
| Jun 30, 2025 | 625,000.00 |
| Jun 30, 2025 | 625,000.00 |
| Mar 31, 2025 | 625,000.00 |
| Mar 31, 2025 | 625,000.00 |
| Dec 31, 2024 | 154,000.00 |
| Dec 31, 2024 | 154,000.00 |
| Sep 30, 2024 | 625,000.00 |
| Sep 30, 2024 | 625,000.00 |
| Jun 30, 2024 | 625,000.00 |
| Jun 30, 2024 | 625,000.00 |
| Mar 31, 2024 | 625,000.00 |
| Mar 31, 2024 | 625,000.00 |
| Dec 31, 2023 | 756,000.00 |
| Dec 31, 2023 | 756,000.00 |